Evidence of oxidative stress in peroxisomal disorders

Singapore Medical Journal

Volumn 53, Issue 9, 2012, Pages 608-614

  El Bassyouni, Hala Tabie ^a   Abdel Maksoud, Soheir A ^b   Salem, Fadia A ^b   El Deen, Reem Badr ^b   Aziz, Hisham Abdel ^a   Thomas, Manal Michel ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Abul Resh Hospital   (Egypt)

Author keywords

Oxidative stress; Peroxisomal disorders; Reactive oxygen species

Indexed keywords

MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; PHYTANIC ACID; SUPEROXIDE DISMUTASE; VERY LONG CHAIN FATTY ACID;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ARTICLE; CHILD; CHONDRODYSPLASIA PUNCTATA; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED AUDITORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INFANT; MALE; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PEROXISOME; PRESCHOOL CHILD; RADIOGRAPHY; REFSUM DISEASE; SCHOOL CHILD; ZELLWEGER SYNDROME;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; EGYPT; HUMANS; INFANT; MALONDIALDEHYDE; MATCHED-PAIR ANALYSIS; NITRIC OXIDE; OXIDATIVE STRESS; PEDIGREE; PEROXISOMAL DISORDERS; SUPEROXIDE DISMUTASE;

EID: 84869988793     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cross C.E, Halliwell B, Borish E.T, et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107:526-545.
2. Leipnitz G, Amaral A.U, Fernandes C.G, et al. Pristanic acid promotes oxidative stress in brain cortex of young rats: a possible pathophysiological mechanism for brain damage in peroxisomal disorders. Brain Res 2011; 1382:259-265.
3. Weller S, Gould S.J, Valle D. Peroxisome biogenesis disorders. Ann. Rev. Genom. Hum Genet 2003; 4:165-211.
4. Krysko O, Bottelbergs A, Van Veldhoven P, Baes M. Combined deficiency of peroxisomal beta-oxidation and ether lipid synthesis in mice causes only minor cortical neuronal migration defects but severe hypotonia. Mol Genet Metab 2010; 100:71-76.
5. Kawada Y, Khan M, Sharma A.K, et al. Inhibition of peroxisomal function due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger-like patients. Mol Genet Metab 2004; 83:297-305.
6. Vargas C.R, Wajner M, Sirtori L.R, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochem Biophys Acta 2004; 1688:26-32.
7. Zaidi S.M, Banu N. Antioxidant potential of vitamins A, E, and C in modulating oxidative stress in rat brain. Clin Chem Acta 2004; 340:229-233.
8. Meagher E.A, FitzGerald G.A. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000; 28:1745-1750.
9. Pryor W.A. Detection of lipid peroxidation products. Free radic Biol Med 1987; 3:317-64.
10. Blokhina O, Virolainen E, Fagerstedt K.V. Antioxidants, Oxidative Damage and Oxygen Deprivation Stress: A Review. Ann Bot 2003; 91:1791-94.
11. Lopez-Huertas E, Charlton W.L, Johnson B, Graham IA, Baker A. Stress induces peroxisome biogenesis genes. EMBO J 2000; 19:6770-6777.
12. Baumgart E.I, Vanhorebeek M, Grabenbauer M.B, et al. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 2001; 159:1477-1494.
13. Schrader M, Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell Biol 2004; 122:383-393.
14. Ferdinandusse S, Denis S, Mooyer P.A.W, et al. Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann Neurol 2005; 59:92-104.
15. Takemoto Y, Suzuki Y, Horibe R, et al. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 2003; 25:481-487.
16. Fukunaga K, Takama K, Suzuki T. High-performance liquid chromatographic determination of plasma malonaldialdehyde level without a solvent extraction procedure. Anal Biochem 1995; 230:20-23.
17. Tsukahara H, Jiang M.Z, Ohta N, et al. Oxidative stress in neonates: Evaluation using specific biomarkers. Life Sci 2004; 75:933-938.
18. Beckman J.S and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiol 1996; 271: C1424-C1437.
19. Hirsh R, Riegl R. Studying a study and testing a test, how to read the medical literature. 2nd ed. Boston: Little, Brown and Company, 1989.
20. Wanders R.J, Waterham H.R. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 2005; 67:107-133.
21. El-Bassyouni H.T, Abdel Mawgoud S.A. Khalipha A.G. Peroxisomal disorders in Egyptian children: estimation of very long chain fatty acids by GC/MS. Med J Cairo Univ 2003; 71:391-401.
22. Giros M, Ruiz M, Ribes A, Pampols T. The diagnosis of peroxisomal disorders in Spain during the period 1987-1997. Rev Neurol 1999; 28:S40-S44.
23. Walter C, Gootjes J, Mooijer P.A, et al. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet 2001; 69:35-48.
24. Grayer J. Recognition of Zellweger syndrome in infancy. Adv Neonatal Care 2005; 5:5-13.
25. Mandel H, Korman S.H. Phenotypic variability (heterogeneity) of peroxisomal disorders. Adv Exp Med Biol 2003; 544:9-30.
26. Cheon J.E, Kim I.O, Hwang Y.S, et al. Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics 2002; 22:461-476.
27. Surdacki A, Tsikas D, Mayatepek E, Frolich J.C. Elevated urinary excretion of nitric oxide metabolites in young infants with Zellweger syndrome. Clin Chim Acta 2003; 334:111-115.
28. Dhaunsi G.S, Kaur J, Alsaeid K, Turner R.B, Bitar M.S. Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts. Cell Biochem Function 2005; 23:65-68.
29. Powers J.M, Pei Z, Heinzer A.K, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005; 64:1067-1079.
30. Khan M, Pahan K, Singh A.K, Singh I. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem 1998; 71:78-87.
31. Biase D.A, Benedetto D.R, Fiorentini C, et al. Free radical release in C6 glial cells enriched in hexacosanoic acid: Implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem Int 2004; 44:215-221.
32. Schonfeld P, Reiser G. Rotenone-like action of the branched-chain phytanic acid induces oxidative stress in mitochondria. J Biol Chem 2006; 281:7136-7142.
33. Leipnitz G, Amaral A.U, Fernandes C.G, et al. Pristanic acid promotes oxidative stress in brain cortex of young rats: a possible pathophysiological mechanism for brain damage in peroxisomal disorders. Brain Res 2011; 1382:259-265.
34. Ferdinandusse S, Finckh B, de Hingh Y.C, et al. Evidence for increased oxidative stress in peroxisomal D-bifunctional protein deficiency. Mol Genet Metab 2003; 79:281-287.